FIA
LEGN icon

FNY Investment Advisers’s Legend Biotech LEGN Stock Holding History

FNY Investment Advisers’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,034
Closed -$56K – 742
2022
Q2 		$56K Buy
+1,034
New +$43.7K 0.04% 221
2020
Q3 		– Sell
-500
Closed -$21K – 556
2020
Q2 		$21K Buy
+500
New +$19.5K 0.01% 246

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

FNY Investment Advisers's LEGN Position: Q3 2022 in Review

FNY Investment Advisers sold out of Legend Biotech (LEGN) in Q3 2022, closing a stake of 1,034 shares — an estimated $56K sold.

FNY Investment Advisers first reported a position in LEGN in Q2 2020 and held it in 2 quarters. The position peaked at $56K in Q2 2022. 159 funds tracked by Wall St. Rank hold LEGN as of Q3 2022.

  • FNY Investment Advisers reported no remaining Legend Biotech position as of Q3 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 1,034 Legend Biotech shares in Q3 2022, an estimated $56K.
  • FNY Investment Advisers first reported a position in Legend Biotech in Q2 2020 and held it in 2 quarters.
  • FNY Investment Advisers's Legend Biotech position peaked at $56K in Q2 2022.
  • 159 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2022.

Based on FNY Investment Advisers's 13F filing for Q3 2022, filed 19 Oct 2022.